Hemoglobin A 1c did not differ between groups
So far Im satisfied with the service and the product
In June 2026 the MHRA approved oral semaglutide, marketed as the Wegovy pill , the first oral GLP-1 receptor agonist licensed in the UK for weight management (distinct from Rybelsus, a lower-dose oral semaglutide licensed for type 2 diabetes)
As a general guide: Signature is ideal for maintenance and general glow, Deluxe adds targeted correction, and Platinum is the most comprehensive option for maximum results
By naturally supporting your body's enteroendocrine signaling and stimulating the release of GLP-1, you may help support metabolic balance, reduce systemic inflammation, and regain control over your appetite without resorting to harsh, potentially risky pharmaceuticals
Tirzepatide in Metabolic Diseases: Clinical Efficacy and Safety Beyond Diabetes and Obesity